PTThe Paper Trail Project
HealthcarePaper Trail research

CVS Health

A healthcare company operating pharmacies, insurance businesses, and pharmacy benefit management services.

Federal spending

Total federal obligations

$4.5M

Obligations recorded from September 23, 2025 through September 22, 2026. Obligations are promises by the federal government to spend money, not necessarily cash already paid.

As of

September 22, 2026

Paper Trail overview

About This Organization

A healthcare company operating pharmacies, insurance businesses, and pharmacy benefit management services.

Editorial context

Why It Is Included

Included because this organization appears in federal spending records and is part of The Paper Trail Project's public-interest research directory.

Paper Trail research

Why you may have heard of it

Known for CVS Pharmacy, Aetna health insurance, and government healthcare programs.

Direct public money received

Public Money Profile

Federal obligations are shown by award type and kept separate from tax incentives or workforce public-benefit research. These categories should not be added into a generic “subsidy” figure.

Federal contracts

$4.5M

Federal grants

$0

Direct payments

$0

Federal loans

$0

Other assistance

$0
Workforce public-benefit research

No published source-backed estimate linked unless shown elsewhere on this profile.

Tax incentives and subsidies

Not included without attributable official records.

Explore where federal money goes →

Connection explorer

Follow the Full Trail

Move from this organization to federal agencies, spending categories, reviewed corporate relationships, lobbying disclosures, its affiliated PAC, and political recipients.

Open Connection Explorer →

Federal data

Spending Over Time

Federal fiscal years

Prime-award transaction obligations attributed to this USAspending recipient. Negative totals can reflect deobligations or corrections.

$831.3K
FY2017
$614.1K
FY2018
$160.2K
FY2019
$39.3M
FY2020
$78.5M
FY2021
$355.7M
FY2022
$130.1M
FY2023
$20.2M
FY2024
$7.1M
FY2025
-$1.2M
FY2026To date

The current fiscal year is partial and will change as USAspending publishes additional transactions.

Federal data

Who funds CVS Health?

The federal agencies and offices responsible for the organization’s recorded obligations.

ConnectedLast refreshed September 22, 2026

Prime-award transaction obligations from 2025-09-23 through 2026-09-22, grouped by top-tier awarding agency.

Federal data

What Federal Agencies Bought or Funded From CVS Health

USAspending classifies federal obligations using product and service codes for contracts and assistance-listing categories for grants and other assistance. These records describe federal awards to the organization—not the organization’s own operating expenses.

Products and services

SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH

PSC B537

$4,439,74799.1% of total
MEDICAL- OTHER

PSC Q999

$404,0009.0% of total
MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES

PSC 6515

-$362,201-8.1% of total

Prime-award transaction obligations from 2025-09-23 through 2026-09-22. Categories can be broad and reflect federal coding, not Paper Trail editorial conclusions. View USAspending source ↗

Federal disclosures

Federal Lobbying

In-house lobbying expenses · 2026 YTD

$0

Expenses reported on filings where the organization registers and lobbies on its own behalf.

Outside lobbying-firm income · 2026 YTD

$730K

Income reported by outside registrants for work on behalf of this client.

These categories are shown separately and are not added together. An organization’s expense estimate may already include payments to outside firms, depending on its reporting method.

Lobbying over time

YearIn-house expensesOutside-firm income
2015$0$670K
2016$0$740K
2017$0$990K
2018$0$1.7M
2019$0$2.2M
2020$0$1.7M
2021$0$1.6M
2022$0$1.7M
2023$0$1.5M
2024$0$895K
2025$0$1.4M
2026$0$730K

What they lobbied on

Health Issues · 148Pharmacy · 140Taxation/Internal Revenue Code · 81Medicare/Medicaid · 53Labor Issues/Antitrust/Workplace · 37Consumer Issues/Safety/Products · 25Budget/Appropriations · 13Insurance · 12Veterans · 9Agriculture · 3Financial Institutions/Investments/Securities · 2Copyright/Patent/Trademark · 1

Outside lobbying firms

Firm / registrantActive filingsReported income
BOCKORNY GROUP, INC.42$3.5M
KOUNTOUPES DENHAM CARR & REID, LLC42$2.6M
KLEIN/JOHNSON GROUP33$2.2M
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ31$1.2M
ALSTON & BIRD LLP30$1.4M
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS28$1.2M
MILLER & CHEVALIER, CHTD22$1.3M
AKIN GUMP STRAUSS HAUER & FELD17$1M
CONTINENTAL STRATEGY, LLC6$575K
MCDERMOTT+4$170K
BAKER & MCKENZIE, LLP4$80K
ML STRATEGIES, LLC3$150K
MICHAEL BEST STRATEGIES LLC2$150K
VANTAGEKNIGHT LLC2$100K

Only the latest filing in each registrant/client/quarter series contributes to these totals.

Lobbyists listed on disclosures

ADAM HECHAVARRIA

Covered position: Legislative Director - Sen.Todd Young,R-IN;Legislative Director-Sen. Kelly Ayotte, R-NH; Budget Analyst-Senate Budget Committee; Legislative Asst,Legislative Aide, Legislative Correspondent, Staff Asst,Correspondence Asst-Sen. John E. Sununu,R-NH

ALEJANDRO GARCIA
ALEXANDER ANGELSON
ALEXANDER GRAF

Covered position: Deputy Assistant Secretary for Legislation, Department of Health and Human Services; Senate Finance Health Subcommittee Staff Director, Legislative Assistant, Legislative Aide, Deputy Scheduler, Staff Assistant, Senator Debbie Stabenow.

ALEXANDRA MINKOVICH
ALLEN JONES JAMERSON

Covered position: Special Assistant - Majority Leader Eric Cantor (13-14); Staff Assistant - Chairman Bob Goodlatte (14-15); Legislative Clerk - Chairman Bob Goodlatte (15-16); Senior Legislative Clerk - Chairman Bob Goodlatte (16)

ARSHI SIDDIQUI
BERNARD ROTHSCHILD

Covered position: Legislative Assistant for Michele Bachmann (07-08); Legislative Assistant for Bill Flores (11); Chief of Staff for Blake Farenthold (12-14); Members Outreach Director for the Committee on House Administration (14-15)

BLAIR C LARKINS

Covered position: Executive Assistant to Rep. Greg Walden (06-10) Staff Assistant to Rep. Greg Walden (05-06)

BRAD HANTLER
BRENDAN DUNN
BRIAN GREER

Covered position: Prof Staff - House Armed Serv, Military Leg Asst - Sen. Chuck Schumer, Special Asst - Sec. of Defense, Military Leg Asst - Rep. John Boccieri, Military Leg Asst - Rep. Parker Griffith, Leg Asst - Rep. David Scott, Staff Assistant, Leg Correspondent

Covered position: Staff Assistant, Leg Correspondent, Leg Asst - Rep. David Scott, Military Leg Asst - Rep. Parker Griffith, Military Leg Asst - Rep. John Boccieri, Special Asst - Sec. of Defense, Military Leg Asst - Sen. Chuck Schumer, Prof Staff - House Armed Serv

BRITTAN SPECHT
CAROLYN MAYLE
CHRISTINA HALEY
DANIEL FERNANDEZ

Covered position: Staff Assistant, Sen. Gordon Smith (04-05); Investigative Assistant, Sen Aging Committee, Chairman/Ranking Member Gordon Smith (05-09); Legislative Assistant, Rep Greg Walden ('11-'13)

DAVID BOCKORNY
DAVID PAUL PELUSO

Covered position: Chief of Staff - Representative Cathy McMorris Rodgers, R-WA; Chief of Staff, Communications Director, Legislative Assistant, Deputy Press Secretary and Executive Assistant - Representative Gus Bilirakis, R-FL.

EARL POMEROY
ED PAGANO
ELINOR HILLER

Covered position: Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS.

FRANK GUINTA
GAVIN PROFFITT
IAN RAYDER

Covered position: Deputy Chief of Staff, Rep. Debbie Wasserman Schultz

ISRAEL S KLEIN

Covered position: Deputy Staff Director, Joint Economic Committee, Chairman Chuck Schumer; Senior Communications Advisor, Representative Ed Markey; Communications Director, Senator Chuck Schumer; Press Secretary and Legislative Assistant, Representative Ed Markey

JAMES PATRICK PALUSKIEWICZ
JANE LUCAS

Covered position: Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, U.S. Senator John Thune.

JASON YAWORSKE
JEFFREY MAXWELL BECKER
JOSE BORJON

Covered position: CoS, Rep V.Gonzalez, Jan 17- Feb 21; Snr Advsr/Dpty CoS, Rep F.Vela, Jun 14- Jan 17; Comm Drctr, Rep Gallego, Dec 13- Jan 15; Drctr Strtgy/Comm, Rep Reyes, Nov 11- Jan 13; Press Sec, Rep Cuellar, Jan 11- Nov 11; Comm Drctr, Rep Ortiz, Mar 09- Jan 11

JOSEPH RUBIN
JOSHUA DAVID ODINTZ

Covered position: Former Tax Counsel - Senate Finance Committee

JULIE HERSHEY CARR

Covered position: Senior Policy Advisor, Legislative Director, Legislative Assistant - Rep. Joe Pitts, R-PA

KATE LYNCH

Covered position: Senior Leg. Asst., Rep John Larson; Leg. Asst., Rep Niki Tsongas; Leg. Asst., Rep. Martin Meehan

KATIE WALDO
KATIE WEIDER
KELLI BRIGGS

Covered position: Chief of Staff, Rep. Pat Tiberi; DC Chief of Staff, Rep. Tiberi; Deputy Chief of Staff, Rep. Tiberi; Legislative Director, Rep. Tiberi; Legislative Assistant, Rep. Tiberi; and Staff Assistant, Rep. Tiberi

KENDALL BYRUM HUSSEY

Covered position: Sen Health Labor Pension Comm, 05-08

LEONARD BICKWIT jr
LESLIE ZELENKO

Covered position: Deputy Assistant Secretary for Legislation, Senior Advisor/Congressional Liaison-HHS; Legislative Director,Senior Legislative Assistant,Legislative Assistant,Legislative Correspondent-Cong. Mark Pocan, D-WI; Staff Assistant-Cong. Tammy Baldwin, D-WI

LISA KOUNTOUPES
LORI DENHAM
LOUIS AGNELLO

Covered position: Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08

MANUEL ORTIZ
MARC J GERSON

Covered position: House Ways & Means Comm., Tax Counsel

MARTI THOMAS
MARTIN DEPOY
MARTINA L. BRADFORD
MARY DEE BEAL

Covered position: Policy Analyst,Senate Republican Policy Committee;Acting Chief of Staff to the Deputy Secretary,USDA;Senior Advisor to the Secretary,USDA;Legislative Director,Cong. Drew Ferguson,R-GA; Legis. Director, Legis. Assistant, Scheduler Cong. Austin Scott,R

MARY R "RANDI" REID
MATTHEW LEE JOHNSON

Covered position: Chief Counsel, Sen. John Cornyn; Senate Judiciary Committee

MAURA KEEFE

Covered position: Chief of Staff, Senator Shaheen -- 2009-2019, Chief of Staff, Rosa DeLauro 1997-2000; press secretary, Rosa DeLauro 1993-1996

MICHAEL PARK
MJ KENNY

Covered position: Deputy Floor Director, Floor Assistant - Office of the Senate Democratic Whip; Legislative Aide, Legislative Correspondent - Senator Richard J. Durbin, (D-IL)

NELEEN EISINGER

Covered position: Legislative staff, Sen. Kent Conrad and U.S. Senate Committee on Finance.

NICOLE VENABLE
NINIO FETALVO
NORMAN FREDERICK LENT iii
PAUL CALKINS jr
PRESTON HILL
RAPHAEL GOODSTEIN

Covered position: Legislative Correspondent, Senator Debbie Stabenow (2002-2004)

ROBERT SIGGINS
RODNEY WHITLOCK

Covered position: 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood

RODNEY WHITLOCK
ROSE SULLIVAN (LISTED IN ERROR)
SAM OLSWANGER
SCOTT STYLES

Covered position: Chief of Staff, Rep. Pete Sessions; Leg. Aide, State Department

THOMAS DASCHLE

Covered position: Former United States Senator

Covered position: Former Senator

Covered position: Former U.S. Senator

TIFFANI VIVIENNE WILLIAMS
TIMOTHY P TRYSLA
VIRGIL MILLER

Covered position: Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19.

ZACHARY RUDISILL

Filing-level audit trail

Superseded filings remain visible for auditability but are excluded from every total above.

2nd Quarter (Apr 1 - June 30) 2026 · BOCKORNY GROUP, INC. · $100K · Active
Filing ID
0edab2f1-500a-45f8-9dc6-d84fe8c6ab72
Filing type
2nd Quarter - Report (Q2)
Registrant
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Amount classification
Outside-firm income
Filed
Jul 20, 2026

Pharmacy

Issues relating to legislation and regulations affecting Pharmacy Benefit Managers.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2026 · ALSTON & BIRD LLP · $20K · Active
Filing ID
3e2896aa-4920-4600-8e75-2eb1f1e6b628
Filing type
2nd Quarter - Report (Q2)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 20, 2026

Health Issues

Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2026 · MICHAEL BEST STRATEGIES LLC · $110K · Active
Filing ID
8e2c5d53-6ab2-47ed-9575-9a58e87d4348
Filing type
2nd Quarter - Report (Q2)
Registrant
MICHAEL BEST STRATEGIES LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 20, 2026

Pharmacy

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Medicare/Medicaid

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Insurance

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Health Issues

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2026 · CONTINENTAL STRATEGY, LLC · $105K · Active
Filing ID
3bbf3a74-41fa-4282-a2b3-ac18f21c8baf
Filing type
2nd Quarter - Report (Q2)
Registrant
CONTINENTAL STRATEGY, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 19, 2026

Health Issues

facilitated meetings and discussions regarding the healthcare industry.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2026 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
8cd293dd-bf1b-431c-8207-f5ee09d349ad
Filing type
2nd Quarter - Report (Q2)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 15, 2026

Pharmacy

Issues related to pharmaceutical supply chains and patient access.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage and Medicaid.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2026 · ALSTON & BIRD LLP · $30K · Active
Filing ID
9934cdd0-f943-4762-9e9b-775c0ba7810c
Filing type
1st Quarter - Report (Q1)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 20, 2026

Health Issues

Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2026 · MICHAEL BEST STRATEGIES LLC · $40K · Active
Filing ID
2e32132f-95f8-4187-835b-61ebd0533b21
Filing type
1st Quarter - Report (Q1)
Registrant
MICHAEL BEST STRATEGIES LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 20, 2026

Health Issues

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Pharmacy

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Medicare/Medicaid

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Insurance

Issues related to retail pharmacies, insurance, and Medicare/Medicaid.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2026 · BOCKORNY GROUP, INC. · $100K · Active
Filing ID
8f70ccae-1b8b-4498-b437-a70e8eff7193
Filing type
1st Quarter - Report (Q1)
Registrant
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Amount classification
Outside-firm income
Filed
Apr 20, 2026

Pharmacy

Issues relating to legislation and regulations affecting Pharmacy Benefit Managers.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2026 · CONTINENTAL STRATEGY, LLC · $105K · Active
Filing ID
b5b591f4-d6bf-4bda-bb85-85acf1132846
Filing type
1st Quarter - Report (Q1)
Registrant
CONTINENTAL STRATEGY, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 17, 2026

Health Issues

facilitated meetings and discussions regarding the healthcare industry.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2026 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
5ae6c5fb-7ca9-4ed4-9161-bac82ea05f6e
Filing type
1st Quarter - Report (Q1)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 15, 2026

Pharmacy

Issues related to pharmaceutical supply chains and patient access.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage and Medicaid.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2026 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Amount not reported · Active
Filing ID
f11bb6bc-665c-412d-80ed-881675384285
Filing type
1st Quarter - Termination (No Activity) (1TY)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
No amount reported
Filed
Apr 15, 2026
Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2026 · KLEIN/JOHNSON GROUP · Amount not reported · Active
Filing ID
7e94cfa1-4c37-489d-9def-7a66190532b8
Filing type
1st Quarter - Termination (No Activity) (1TY)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
No amount reported
Filed
Apr 9, 2026
Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2025 · KLEIN/JOHNSON GROUP · $50K · Active
Filing ID
f178cf93-08df-4b30-8b19-7a58378361b6
Filing type
4th Quarter - Report (Q4)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 20, 2026

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2025 · ALSTON & BIRD LLP · $30K · Active
Filing ID
88925ecd-46b9-4af9-af14-555793998d3d
Filing type
4th Quarter - Report (Q4)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 20, 2026

Health Issues

Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2025 · BOCKORNY GROUP, INC. · $105K · Active
Filing ID
aa04e101-ca51-4415-8052-9be24b84fa21
Filing type
4th Quarter - Report (Q4)
Registrant
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Amount classification
Outside-firm income
Filed
Jan 20, 2026

Pharmacy

Issues relating to legislation and regulations affecting Pharmacy Benefit Managers.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2025 · CONTINENTAL STRATEGY, LLC · $105K · Active
Filing ID
f6ed8916-f711-48b0-bf78-f15e52b62676
Filing type
4th Quarter - Report (Q4)
Registrant
CONTINENTAL STRATEGY, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 19, 2026

Health Issues

facilitated meetings and discussions regarding the healthcare industry.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
8fb4eef6-cf55-40b1-81d6-e2621c044670
Filing type
4th Quarter - Report (Q4)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 15, 2026

Pharmacy

Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage and Medicaid.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2025 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $30K · Active
Filing ID
2cc5ab41-493c-4a75-a461-2f2cd25681df
Filing type
4th Quarter - Report (Q4)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 15, 2026

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2025 · CONTINENTAL STRATEGY, LLC · $105K · Active
Filing ID
0c655167-5ae1-40dd-bef6-eef734e45d2f
Filing type
3rd Quarter - Report (Q3)
Registrant
CONTINENTAL STRATEGY, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 20, 2025

Health Issues

facilitated meetings and discussions regarding the healthcare industry.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2025 · KLEIN/JOHNSON GROUP · $50K · Active
Filing ID
5beb68f9-dffe-4489-9297-3b8032d65652
Filing type
3rd Quarter - Report (Q3)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 20, 2025

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2025 · ALSTON & BIRD LLP · $30K · Active
Filing ID
07c0fc01-71cb-4216-bad4-bcd6144eb421
Filing type
3rd Quarter - Report (Q3)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 20, 2025

Health Issues

Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2025 · BOCKORNY GROUP, INC. · $105K · Active
Filing ID
0348900b-e79f-40a9-96b3-1af8ef2a1df5
Filing type
3rd Quarter - Report (Q3)
Registrant
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Amount classification
Outside-firm income
Filed
Oct 20, 2025

Pharmacy

Issues relating to legislation and regulations affecting Pharmacy Benefit Managers.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2025 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $30K · Active
Filing ID
89b14f12-9b6b-4f5a-ba2a-f1ac1e59fb22
Filing type
3rd Quarter - Report (Q3)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 15, 2025

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
57809e38-76c3-4c6f-b5c7-f09bfcad8009
Filing type
3rd Quarter - Report (Q3)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 14, 2025

Pharmacy

Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage and Medicaid.

Insurance

Issues related to employer, small group, and individual insurance markets.

Health Issues

Issues related to telehealth and remote patient monitoring.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2025 · ALSTON & BIRD LLP · $40K · Active
Filing ID
c88d16ac-4dcd-43a9-a3b0-e98d7af0ee92
Filing type
2nd Quarter - Report (Q2)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 21, 2025

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2025 · KLEIN/JOHNSON GROUP · $50K · Active
Filing ID
b88249bf-5119-4706-9fa0-e76f8f0a0734
Filing type
2nd Quarter - Report (Q2)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 21, 2025

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2025 · BOCKORNY GROUP, INC. · $105K · Active
Filing ID
394e1b8d-5a55-4fdd-9854-b2f077a37bee
Filing type
2nd Quarter - Report (Q2)
Registrant
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Amount classification
Outside-firm income
Filed
Jul 21, 2025

Pharmacy

Issues relating to legislation and regulations affecting Pharmacy Benefit Managers.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2025 · CONTINENTAL STRATEGY, LLC · $105K · Active
Filing ID
cdc1abaa-9016-4389-aeee-8de4299b1ab4
Filing type
2nd Quarter - Report (Q2)
Registrant
CONTINENTAL STRATEGY, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 18, 2025

Health Issues

facilitated meetings and discussions regarding the healthcare industry.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2025 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $25K · Active
Filing ID
38e88ac4-745b-48ed-8e9f-3b76b1a78132
Filing type
2nd Quarter - Report (Q2)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 18, 2025

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
01d39795-baeb-42b9-bb07-55809bece7b9
Filing type
2nd Quarter - Report (Q2)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 16, 2025

Pharmacy

Issues related to pharmaceutical supply chains and patient access.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage and Medicaid.

Insurance

Issues related to employer, small group, and individual insurance markets.

Health Issues

Issues related to telehealth and remote patient monitoring.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2025 · CONTINENTAL STRATEGY, LLC · $50K · Active
Filing ID
6706e90e-d5a5-48c3-8aab-008519370d43
Filing type
1st Quarter - Amendment (1A)
Registrant
CONTINENTAL STRATEGY, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
May 7, 2025

Health Issues

facilitated meetings and discussions regarding the healthcare industry.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2025 · ALSTON & BIRD LLP · $30K · Active
Filing ID
6ccf3b18-5301-4acf-b799-2f395b7f52e6
Filing type
1st Quarter - Report (Q1)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 21, 2025

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2025 · KLEIN/JOHNSON GROUP · $50K · Active
Filing ID
89ecce08-c0d3-4e8d-8a0d-17a67689a249
Filing type
1st Quarter - Report (Q1)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 21, 2025

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2025 · BOCKORNY GROUP, INC. · $40K · Active
Filing ID
44921e7a-c322-45f9-b277-a3390263d4f7
Filing type
1st Quarter - Report (Q1)
Registrant
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Amount classification
Outside-firm income
Filed
Apr 21, 2025

Pharmacy

Issues relating to legislation and regulations affecting Pharmacy Benefit Managers.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
0499739e-1b04-4d9a-b2b9-fbc48ac5dd7c
Filing type
1st Quarter - Report (Q1)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 14, 2025

Pharmacy

Issues related to pharmaceutical supply chains.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage and Medicaid.

Insurance

Issues related to employer, small group, and individual insurance markets.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2025 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $25K · Active
Filing ID
baf857bf-ce81-49fc-9acb-d7c54d2afdf7
Filing type
1st Quarter - Report (Q1)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 10, 2025

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2024 · ALSTON & BIRD LLP · $70K · Active
Filing ID
04c359a6-4412-48ad-b1f8-f567597799ec
Filing type
4th Quarter - Report (Q4)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 21, 2025

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2024 · KLEIN/JOHNSON GROUP · $70K · Active
Filing ID
67b122e7-970f-4e33-895f-0a46006a0e1d
Filing type
4th Quarter - Report (Q4)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 21, 2025

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2024 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $15K · Active
Filing ID
4e88fe06-02e9-43ed-904c-3ee3d6f93cff
Filing type
4th Quarter - Report (Q4)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 20, 2025

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2024 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
be7f9ffa-f62d-48c8-8e45-dcf0a32de20b
Filing type
4th Quarter - Report (Q4)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 15, 2025

Pharmacy

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.

Insurance

Issues related to employer, small group and individual insurance markets.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2024 · KLEIN/JOHNSON GROUP · $70K · Active
Filing ID
fd1b68e8-f81b-4cf6-a05a-851de00649e7
Filing type
3rd Quarter - Report (Q3)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 21, 2024

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement.

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2024 · ALSTON & BIRD LLP · $60K · Active
Filing ID
6099f6c4-3401-4552-8be6-3841a9b1a541
Filing type
3rd Quarter - Report (Q3)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 21, 2024

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2024 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
156d758b-e789-4266-8548-301af67f54e4
Filing type
3rd Quarter - Report (Q3)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 16, 2024

Pharmacy

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.

Insurance

Issues related to employer, small group and individual insurance markets.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2024 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $30K · Active
Filing ID
6211d5ab-e322-4f2a-bece-cafafdedff54
Filing type
3rd Quarter - Report (Q3)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 12, 2024

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2024 · KLEIN/JOHNSON GROUP · $70K · Active
Filing ID
5df4f256-e187-40b6-b901-c187501d4f0c
Filing type
2nd Quarter - Report (Q2)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 22, 2024

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2024 · ALSTON & BIRD LLP · $60K · Active
Filing ID
7e8d2444-36a7-46c6-a65a-651757e464a3
Filing type
2nd Quarter - Report (Q2)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 22, 2024

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2024 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
551293eb-1454-4f31-845e-fb140ad9f5e5
Filing type
2nd Quarter - Report (Q2)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jul 15, 2024

Pharmacy

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.

Insurance

Issues related to employer, small group and individual insurance markets, including surprise billing and ACA subsidies.

Official LDA filing ↗
2nd Quarter (Apr 1 - June 30) 2024 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $30K · Active
Filing ID
b802b3d8-9f3a-4bb5-afb8-188872da3d83
Filing type
2nd Quarter - Report (Q2)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jun 28, 2024

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2024 · KLEIN/JOHNSON GROUP · $70K · Active
Filing ID
0826ef0f-f308-42e1-b1c3-3ab01d495ae9
Filing type
1st Quarter - Report (Q1)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 22, 2024

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2024 · ALSTON & BIRD LLP · $80K · Active
Filing ID
2e1cfd28-9a4f-4730-82c9-ecba929bb630
Filing type
1st Quarter - Report (Q1)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 22, 2024

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2024 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $30K · Active
Filing ID
b9579401-f3ff-469c-8c14-ef9270157af6
Filing type
1st Quarter - Report (Q1)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 12, 2024

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
1st Quarter (Jan 1 - Mar 31) 2024 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
Filing ID
c21cbecf-abf6-479a-bf9e-e7bfd7f7b871
Filing type
1st Quarter - Report (Q1)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Apr 9, 2024

Pharmacy

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.

Insurance

Issues related to employer, small group and individual insurance markets, including surprise billing and ACA subsidies.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2023 · KLEIN/JOHNSON GROUP · $70K · Active
Filing ID
d4862ad2-1472-4100-8a40-779924933f87
Filing type
4th Quarter - Report (Q4)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 22, 2024

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2023 · ALSTON & BIRD LLP · $70K · Active
Filing ID
bd49a378-b38d-48bc-b97b-ea45d0a201b0
Filing type
4th Quarter - Report (Q4)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 22, 2024

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2023 · BOCKORNY GROUP, INC. · $50K · Active
Filing ID
82ef9ef0-3db0-4b2e-9b72-d5a2a2329cc9
Filing type
4th Quarter - Report (Q4)
Registrant
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Amount classification
Outside-firm income
Filed
Jan 20, 2024

Pharmacy

Issues related to drug pricing Issues related to health reform proposals Issues related to representation in COVID-19-related packages HR 1770 - Equitable Community Access to Pharmacist Services Act Issues related to Pharmacy Benefit Managers

Budget/Appropriations

Issues related to hospital payments Issues related to hospital inclusion and representation in COVID-19 packages; HR 1770 Public Law Number 116-136 CARES Act H.R. 1868 An Act to prevent across-the-board direct spending cuts, and for other purposes

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2023 · KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · $30K · Active
Filing ID
9b2f4c61-1846-4510-a5ae-bb7e70baf650
Filing type
4th Quarter - Report (Q4)
Registrant
KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 16, 2024

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Official LDA filing ↗
4th Quarter (Oct 1 - Dec 31) 2023 · KOUNTOUPES DENHAM CARR & REID, LLC · $80K · Active
Filing ID
73bb57d7-4ea9-4b60-85cb-6d3610b103b2
Filing type
4th Quarter - Report (Q4)
Registrant
KOUNTOUPES DENHAM CARR & REID, LLC
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Jan 12, 2024

Pharmacy

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.

Insurance

Issues related to employer, small group and individual insurance markets, including surprise billing and ACA subsidies.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2023 · ALSTON & BIRD LLP · $90K · Active
Filing ID
36df34d1-c2ac-435f-94af-b369f8821290
Filing type
3rd Quarter - Report (Q3)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 20, 2023

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2023 · ALSTON & BIRD LLP · $90K · Superseded
Filing ID
3da06b70-5ef4-4b41-9170-c5d0a17a47fe
Filing type
3rd Quarter - Report (Q3)
Registrant
ALSTON & BIRD LLP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 20, 2023
Superseded by
36df34d1-c2ac-435f-94af-b369f8821290

Health Issues

Issues related to the implementation of health care reform and issues related to PBMs and drug pricing.

Official LDA filing ↗
3rd Quarter (July 1 - Sep 30) 2023 · KLEIN/JOHNSON GROUP · $70K · Active
Filing ID
9a813b19-0d94-498f-8739-0520ccf9b24f
Filing type
3rd Quarter - Report (Q3)
Registrant
KLEIN/JOHNSON GROUP
Client
CVS HEALTH
Amount classification
Outside-firm income
Filed
Oct 20, 2023

Labor Issues/Antitrust/Workplace

Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain.

Pharmacy

General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin.

Consumer Issues/Safety/Products

Issues related to organized retail crime enforcement.

Official LDA filing ↗
Source: U.S. House and Senate Lobbying Disclosure Act database / LDA.gov. Data last retrieved Sep 6, 2026. The Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.

Documentation

Sources

For researchers

Cite this page

The Paper Trail Project. “CVS Health.” Accessed September 23, 2026. https://www.papertrailproject.org/profiles/cvs-health

Methodology

Record last updated 2026-09-22. Sources: Linked public records. Verify consequential claims against the linked original records.